Investigation of the effect of erythrosine B on amyloid beta peptide using molecular modeling

Journal of Molecular Modeling

Volumn 22, Issue 4, 2016, Pages

  Lee, Juho ^a   Kwon, Inchan ^b,c   Jang, Seung Soon ^d   Cho, Art E ^a  

^a Korea University   (South Korea)

^b University of Virginia   (United States)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

^d Georgia Institute of Technology   (United States)

Author keywords

Alzheimer s disease; Amyloid beta; Erythrosine B; Molecular dynamics; Pi stacking

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; ASPARTIC ACID; ERYTHROSINE; LYSINE; AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT; PROTEIN BINDING; WATER;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DRUG EFFECT; DRUG PROTEIN BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CHEMICAL PHENOMENA; CHEMISTRY; HUMAN; HYDROGEN BOND; PROTEIN DOMAIN; STATIC ELECTRICITY; THERMODYNAMICS;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ASPARTIC ACID; BINDING SITES; ERYTHROSINE; HUMANS; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LYSINE; MOLECULAR DYNAMICS SIMULATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN DOMAINS; PROTEIN STRUCTURE, SECONDARY; STATIC ELECTRICITY; THERMODYNAMICS; WATER;

EID: 85008490070     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-016-2960-x     Document Type: Article

References (52)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia 7(3):270–279. doi:10.1016/j.jalz.2011.03.008
2. Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283(44):29615–29619. doi:10.1074/jbc.R800019200
3. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory. Nat Med 14(8):837–842. doi:10.1038/nm1782
4. Sun (2012) Review of drugs for Alzheimer’s disease. Drug Discov Therapeut. doi:10.5582/ddt.2012.v6.6.285
5. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356. doi:10.1126/science.1072994
6. Wong HE, Irwin JA, Kwon I (2013) Halogenation generates effective modulators of amyloid-beta aggregation and neurotoxicity. PLoS ONE 8(2):e57288. doi:10.1371/journal.pone.0057288
7. Wong HE, Kwon I (2011) Xanthene food dye, as a modulator of Alzheimer’s disease amyloid-beta peptide aggregation and the associated impaired neuronal cell function. PLoS ONE 6(10):e25752. doi:10.1371/journal.pone.0025752
8. Irwin JA, Edward Wong H, Kwon I (2015) Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies. Anal Biochem 470:61–70. doi:10.1016/j.ab.2014.10.016
9. Wong HE, Qi W, Choi HM, Fernandez EJ, Kwon I (2011) A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-beta neurotoxicity by generating nontoxic aggregates. ACS Chem Neurosci 2(11):645–657. doi:10.1021/cn200056g
10. Ishii K, Klunk WE, Arawaka S, Debnath ML, Furiya Y, Sahara N, Si S, Tamaoka A, Pettegrew JW, Mori H (2002) Chrysamine G and its derivative reduce amyloid β-induced neurotoxicity in mice. Neurosci Lett 333(1):5–8. doi:10.1016/S0304-3940(02)00915-1
11. Liu F-F, Dong X-Y, He L, Middelberg APJ, Sun Y (2011) Molecular insight into conformational transition of amyloid β-Peptide 42 inhibited by (−)-Epigallocatechin-3-gallate probed by molecular simulations. J Phys Chem B 115(41):11879–11887. doi:10.1021/jp202640b
12. Reznichenko L, Amit T, Zheng H, Avramovich-Tirosh Y, Youdim MBH, Mandel S (2006) Reduction of iron-regulated amyloid precursor protein and β-amyloid peptide by (–)-epigallocatechin-3gallate in cell cultures: implications for iron chelation in Alzheimer’s disease. J Neurochem 97(2):527–536. doi:10.1111/j. 1471-4159.2006.03770.x
13. Watson DJ, Lander AD, Selkoe DJ (1997) Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. dependence on aggregation state and inhibition by Congo red. J Biol Chem 272(50):31617–31624
14. Pratim Bose P, Chatterjee U, Xie L, Johansson J, Göthelid E, Arvidsson PI (2010) Effects of congo red on Aβ1−40 fibril formation process and morphology. ACS Chem Neurosci 1(4):315–324. doi:10.1021/cn900041x
15. Lee C, Ham S (2011) Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water. J Comput Chem 32(2):349–355. doi:10.1002/jcc.21628
16. Li J, Liu R, Lam KS, Jin L-W, Duan Y (2011) Alzheimer’s disease drug candidates stabilize A-β protein native structure by interacting with the hydrophobic core. Biophys J 100(4):1076–1082. doi:10.1016/j.bpj.2010.12.3741
17. Yang C, Zhu X, Li J, Shi R (2010) Exploration of the mechanism for LPFFD inhibiting the formation of β-sheet conformation of Aβ(1–42) in water. J Mol Model 16(4):813–821. doi:10.1007/s00894-009-0594-y
18. Triguero L, Singh R, Prabhakar R (2008) Molecular dynamics study to investigate the effect of chemical substitutions of methionine 35 on the secondary structure of the amyloid β (Aβ(1−42)) monomer in aqueous solution. J Phys Chem B 112(7):2159–2167. doi:10.1021/jp0771872
19. Brown AM, Lemkul JA, Schaum N, Bevan DR (2014) Simulations of monomeric amyloid β-peptide (1–40) with varying solution conditions and oxidation state of Met35: implications for aggregation. Arch Biochem Biophys 545:44–52. doi:10.1016/j.abb.2014.01.002
20. Yang C, Li J, Li Y, Zhu X (2009) The effect of solvents on the conformations of Amyloid β-peptide (1–42) studied by molecular dynamics simulation. J Mol Struct (THEOCHEM) 895(1–3):1–8. doi:10.1016/j.theochem.2008.10.003
21. Schrodinger, LLC (2014) Maestro, version 9.8. Schrodinger, LLC, New York
22. Levitan H (1977) Food, drug, and cosmetic dyes: biological effects related to lipid solubility. Proc Natl Acad Sci 74(7):2914–2918
23. Schrodinger, LLC (2014) Jaguar, version 8.4. Schrodinger, LLC, New York
24. Koziara K, Stroet M, Malde A, Mark A (2014) Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies. J Comput Aided Mol Des 28(3): 221–233. doi:10.1007/s10822-014-9713-7
25. Hess B, Kutzner C, van der Spoel D, Lindahl E (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4(3):435–447. doi:10.1021/ct700301q
26. Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B, Lindahl E (2013) GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29(7):845–854. doi:10.1093/bioinformatics/btt055
27. Schmid N, Eichenberger A, Choutko A, Riniker S, Winger M, Mark A, van Gunsteren W (2011) Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J 40(7):843–856. doi:10.1007/s00249-011-0700-9
28. Huang W, Lin Z, van Gunsteren WF (2011) Validation of the GROMOS 54A7 force field with respect to β-peptide folding. J Chem Theory Comput 7(5):1237–1243. doi:10.1021/ct100747y
29. Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ (1998) Solution structure of amyloid β-peptide(1−40) in a water−micelle environment. is the membrane-spanning domain where we think it is? Biochemistry 37(31):11064–11077. doi:10.1021/bi972979f
30. Vivekanandan S, Brender JR, Lee SY, Ramamoorthy A (2011) A partially folded structure of amyloid-beta(1-40) in an aqueous environment. Biochem Biophys Res Commun 411:312-316. doi: 10.1016/j.bbrc.2011.06.133
31. Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J (1981) Interaction models for water in relation to protein hydration. In: Pullman B (ed) Intermolecular forces, vol 14. the Jerusalem Symposia on Quantum Chemistry and Biochemistry. Springer, Dordrecht, pp 331–342. doi:10.1007/978-94-015-7658-1_21
32. Cuendet MA, van Gunsteren WF (2007) On the calculation of velocity-dependent properties in molecular dynamics simulations using the leapfrog integration algorithm. J Chem Phys 127(18): 184102. doi:10.1063/1.2779878
33. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J Chem Phys 98(12):10089–10092. doi:10.1063/1.464397
34. Hess B (2008) P-LINCS: a parallel linear constraint solver for molecular simulation. J Chem Theory Comput 4(1):116–122. doi:10.1021/ct700200b
35. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81(8):3684–3690. doi:10.1063/1.448118
36. Nosé S (1984) A unified formulation of the constant temperature molecular dynamics methods. J Chem Phys 81(1):511–519. doi:10.1063/1.447334
37. Hoover WG (1985) Canonical dynamics: equilibrium phase-space distributions. Phys Rev A 31(3):1695–1697
38. Horta BAC, Fuchs PFJ, van Gunsteren WF, Hünenberger PH (2011) New interaction parameters for oxygen compounds in the GROMOS force field: improved pure-liquid and solvation properties for alcohols, ethers, aldehydes, ketones, carboxylic acids, and esters. J Chem Theory Comput 7(4):1016–1031. doi:10.1021/ct1006407
39. Jarzynski C (1997) Nonequilibrium equality for free energy differences. Phys Rev Lett 78(14):2690–2693
40. Hess B, Peter C, Ozal T, van der Vegt NFA (2008) Fast-growth thermodynamic integration: calculating excess chemical potentials of additive molecules in polymer microstructures. Macromolecules 41(6):2283–2289. doi:10.1021/ma702070n
41. Oostenbrink C, van Gunsteren WF (2005) Free energies of ligand binding for structurally diverse compounds. Proc Natl Acad Sci U S A 102(19):6750–6754. doi:10.1073/pnas.0407404102
42. Oostenbrink C, van Gunsteren WF (2006) Calculating zeros: nonequilibrium free energy calculations. Chem Phys 323(1):102–108. doi:10.1016/j.chemphys.2005.08.054
43. Hummer G, Szabo A (2001) Free energy reconstruction from nonequilibrium single-molecule pulling experiments. Proc Natl Acad Sci 98(7):3658–3661. doi:10.1073/pnas.071034098
44. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22(12):2577–2637. doi:10.1002/bip.360221211
45. Connolly M (1983) Analytical molecular surface calculation. J Appl Crystallogr 16(5):548–558. doi:10.1107/S0021889883010985
46. McGaughey GB, Gagne M, Rappe AK (1998) pi-Stacking interactions. alive and well in proteins. J Biol Chem 273(25):15458–15463
47. Gazit E (2002) A possible role for pi-stacking in the self-assembly of amyloid fibrils. Faseb J 16(1):77–83
48. Lemkul JA, Bevan DR (2010) Assessing the stability of Alzheimer’s amyloid protofibrils using molecular dynamics. J Phys Chem B 114(4):1652–1660. doi:10.1021/jp9110794
49. Reddy G, Straub JE, Thirumalai D (2009) Influence of preformed Asp23−Lys28 salt bridge on the conformational fluctuations of monomers and dimers of Aβ peptides with implications for rates of fibril formation. J Phys Chem B 113(4):1162–1172. doi:10.1021/jp808914c
50. Battaglia MR, Buckingham AD, Williams JH (1981) The electric quadrupole moments of benzene and hexafluorobenzene. Chem Phys Lett 78(3):421–423. doi:10.1016/0009-2614(81)85228-1
51. Bartolini M, Bertucci C, Bolognesi ML, Cavalli A, Melchiorre C, Andrisano V (2007) Insight into the kinetic of amyloid β (1–42) peptide self-aggregation: elucidation of inhibitors’ mechanism of action. ChemBioChem 8(17):2152–2161. doi:10.1002/cbic.200700427
52. Williamson Mike P, Suzuki Y, Bourne Nathan T, Asakura T (2006) Binding of amyloid β-peptide to ganglioside micelles is dependent on histidine-13. Biochem J 397(Pt 3):483–490. doi:10.1042/bj20060293